Health
Explainer: What is Monkeypox Virus?

By Adedapo Adesanya
In a world where the coronavirus is still around, attention may shift to the Monkeypox virus – which has been found in Australia, the United States, and some top countries in Europe.
What is the Monkeypox Virus?
According to a World Health Organisation (WHO) research, the Monkeypox virus is a virus that is transmitted to humans from animals. The first case was discovered back in a small child back in 1970 in the Democratic Republic of the Congo.
It is a rare disease caused by the monkeypox virus, part of the same family as smallpox, though typically less severe. The incubation period of the newly spreading Monkeypox virus ranges from 6 to 13 days. However, it might be from 5 to 21 days.
Symptoms
Symptoms such as fever, intense headache, lymphadenopathy, back pain, myalgia (muscle aches), and an intense asthenia (lack of energy) usually appear in the patients who test positive for the Monkeypox virus. On the other hand, skin eruption usually starts within 1-3 days of the appearance of fever. The rash appears mostly on the face and extremities rather than on the chest.
History in Nigeria
There have since been sporadic cases reported across 10 African countries, including Nigeria, which in 2017 experienced the largest documented outbreak, with 172 suspected and 61 confirmed cases. In terms of age, 75 per cent of those affected were males aged 21 to 40 years old.
Cases outside of Africa have historically been less common and typically linked to international travel or imported animals.
How Can One Catch Monkeypox?
Monkeypox spreads when someone comes into close contact with another person, animal or material infected with the virus. The virus can enter the body through broken skin, the respiratory tract or through the eyes, nose and mouth. Human to human transmission most commonly occurs through respiratory droplets, though usually requires prolonged face-to-face contact.
Animal to human transmission meanwhile may occur via a bite or scratch but the disease is not generally considered a sexually transmitted disease, though it can be passed on during sex.
Available Treatment
There are currently no proven, safe treatments for monkeypox, though most cases are mild. In the past, researchers said that vaccination against smallpox with the vaccinia vaccine was proved through several observational studies to be about 85 per cent effective in preventing the Monkeypox virus.
A newer vaccinia-based vaccine was approved for the prevention of smallpox and monkeypox in 2019 and is also not yet widely available in the public sector. Countries including the United Kingdom and Spain are now offering the vaccine to those who have been exposed to infections to help reduce symptoms and limit the spread.
Can it Kill?
Monkeypox cases can occasionally be more severe, with some deaths having been reported in West Africa. However, health authorities stress that we are not on the brink of a serious outbreak and the risks to the general public remain very low.
What are Health Regulators Saying?
WHO says it continues to closely monitor as the situation is evolving rapidly. It is supporting member states with surveillance, preparedness, and outbreak response activities for monkeypox in affected countries.
Health authorities in the United Kingdom, the United States, and Canada urged people who experience new rashes or are concerned about monkeypox to contact their healthcare provider.
WHO also clarified that does it not recommend any restrictions for travel based on available information at this time.
Health
AXA Mansard Health Reaffirms Commitment to Customer-first Policy

By Modupe Gbadeyanka
Customers of AXA Mansard Health have been reassured that they would remain a priority and all efforts would be made to ensure they get value for their money.
The chief executive of the leading health insurance provider in Nigeria, Mr Tope Adeniyi, reiterated this commitment at the company’s South-West Provider Forum in Ibadan, recently.
Mr Adeniyi emphasised that millions of AXA Mansard Health customers across the country would continue to receive quality healthcare, no matter what.
“For us at AXA Mansard Health, it’s about the customer first. It’s not just a core value; it’s the mantra that guides everything we do from innovation to process improvement, product development and even our CSR initiatives. We are a company built on protecting what matters to our customers,” he stated.
The AXA Mansard Health chief explained that the forum was put together to engage with its providers to jointly chat the best ways to ensure that AXA customers receive the best healthcare services.
“We know that it is our providers that complete this value-chain of superior customer service; the hospitals, the clinics, the laps, and so on. That’s how our customers experience us.
“So, we are here today to consolidate on the partnership, so our customers can always get the best.
“Our customers are always first, and they are followed by our providers. We are convinced that if we keep this model, we will remain the brand to beat in Nigeria.
“Our wider plan is to touch all corners of Nigeria and bring premium healthcare services to every Nigerian because they deserve it.
“These forums are crucial in building strong partnerships with our providers, which ultimately lead to better healthcare outcomes for our customers,” he said.
Business Post reports that the forum, which has been held previously in various cities, including Lagos, Port Harcourt, Sokoto, Maiduguri, Ibadan, and Abuja over the last four months, underscores AXA Mansard Health’s commitment to bridging the healthcare gap and ensuring that premium healthcare services are accessible to all Nigerians, not just those in major cities.
This nationwide reach ensures that the benefits of these engagements are felt across the country, fostering collaboration and sharing best practices needed to address the unique healthcare challenges faced by different parts of the country.
Nigeria faces significant healthcare challenges, with only about 4.08 per cent of its Gross Domestic Product (GDP) spent on healthcare.
The country has a doctor-to-patient ratio of approximately 1 to 10,000, far below the World Health Organization’s recommendation of 1 to 600.
With healthcare access unevenly distributed across the country and rural areas experiencing higher out-of-pocket expenses for healthcare compared to urban zones, there is an urgent need for initiatives like the providers forum to improve healthcare delivery for all Nigerians.
AXA Mansard Health says it is committed to enhancing its products and services through these forums while also working on improving the overall healthcare experience for its customers.
The company plans to hold future forums in the South East region in the coming months, further demonstrating its dedication to ensuring quality healthcare is accessible to all.
“As we progress further into 2025, the insights and feedback gathered from these forums will play a pivotal role in shaping our company’s strategies to enhance customer experience and ensure that quality healthcare is accessible to all Nigerians,” Mr Adeniyi concluded.
Health
i3 to Fund mPharma, Six Others Transforming Pharmacy Care in Africa

By Adedapo Adesanya
Investing in Innovation Africa (i3), a pan-African initiative to support African healthtech startups to commercialise and scale their offerings, has announced its 3rd cohort of seven growth-stage companies working to transform pharmacy services on the continent.
Sponsored by the Gates Foundation, MSD, Cencora (formerly AmerisourceBergen), Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), Sanofi’s Global Health Unit and Chemonics, the three-year programme will empower innovators to improve patient access to healthcare across Africa and scale their impact.
i3 is coordinated by Salient Advisory and Solina Center for International Development and Research (SCIDaR).
The selected startups include mPharma, Chefaa, Dawa Mkononi, Meditect, myDawa, RxAll, and Sproxil.
These startups were selected by an expert committee and with the support of CcHUB and Villgro Africa and an independent expert advisory committee.
According to a statement, they will each receive up to $225,000 in risk-tolerant funding, tailored customer introductions, bespoke deal facilitation, and professional communications and advocacy support.
i3 also aims to facilitate around 150 strategic partnerships and influence deals valued at $30M million between innovators and major healthcare purchasers.
In addition, the cohort will participate in i3’s flagship Access to Markets event in December 2025, designed to spark high-impact partnerships between innovators and large healthcare companies, governments, donors, and multilateral agencies.
In the past two years, i3 has provided $3 million in direct grant funding to 60 start-ups across 16 African countries. The program has also established a diverse cohort of innovators, with 43 per cent being women-led and 20 per cent Francophone-led.
According to a statement, successes have recorded 450 facilitated strategic connections, including 122 contracts and pilots, resulting in $11 million in contracted partnerships, expanded reach, and nearly 1,000 jobs created—half of which were held by women.
Speaking on the latest move, Mr Boniface Njenga, Deputy Director, Health Delivery and Systems, Africa at the Gates Foundation, commented: “As the global health landscape continues to rapidly shift, we remain committed to supporting innovative solutions and initiatives that strengthen local health systems across Africa. The i3 program emphasises the transformative potential of technology-driven innovations on the continent when empowered with the right resources, and we have already seen impressive results from the cohorts.”
On her part, Dr Priya Agrawal, Vice President, International Health Equity and Partnerships, at MSD, noted: “Now more than ever, investing in local healthcare businesses is essential for securing effective and sustainable medicine and vaccine distribution across Africa. MSD is committed to partnering with i3 to support entrepreneurs that are dedicated to expanding equitable healthcare access. By engaging the local private sector and meeting patients where they are, we can enhance access and strengthen health systems through fostering innovation in pharmacy services.”
For Dr Ashifi Gogo, CEO and Founder at Sproxil, remarked: “It is an honor to be selected as part of the i3 cohort focused on growth-stage companies. The support of leading global life sciences and logistics companies, alongside forward-thinking foundations, is encouraging as we scale our impact. The i3 program continues to differentiate itself through the transformative power of local innovation, and I am eager to see the significant impact this cohort will undoubtedly make.”
Health
Dangote’s Foundation Gives Ambulance to Mainland Hospital Yaba

By Modupe Gbadeyanka
An ambulance has been donated to the Mainland Hospital Yaba, Lagos, by the Aliko Dangote Foundation (ADF), the first the health facility was getting in the past decade.
The chief medical director of the organisation, Mr Adejumo Adedeji Olusola, while receiving the item last Friday, emphasized how crucial the donation was, describing patient mobility as a longstanding challenge.
“Today we received an ambulance from Aliko Dangote Foundation to support our response activities in Lagos. Aliko Dangote Foundation has taken care of our biggest headache; in fact, it is a game changer for us, so we can do a lot of things now that we can’t do before,” the medical practitioner stated.
He further acknowledged the impact of private sector support, particularly expressing appreciation to Mr Aliko Dangote for addressing a decade-long need.
“We are really grateful, and our sincere gratitude goes to Mr Aliko Dangote. We lacked an ambulance for about 10 years, but now we have one we can boast of thanks to Mr Aliko Dangote. Thank you very much,” he said.
In his remarks, the Director of Health and Nutrition for the ADF, Mr Francis Aminu, reiterated the foundation’s unwavering dedication to improving the lives of Nigerians, particularly in the health sector.
He opined that the ambulance would bolster Mainland Hospital Yaba’s capacity to manage infectious disease outbreaks and enhance emergency response.
“We are happy to help. The foundation is there to assist, especially in areas of health. They say health is wealth, so the foundation is there to fill the gaps found and through this donation initiative, this is us (ADF) showing our commitment to ensuring those needs are met.
“What we do at ADF isn’t just charity, it’s a duty. We believe that every Nigerian life is valuable, and health is the foundation on which all other aspirations are built; no Nigerian should be left behind due to a lack of access to essential health resources.
“This isn’t a one-time effort; we are committed to building systems that last, ones that Nigerians can rely on even in the toughest of times,” the remarked.
The ambulance is expected to serve as a game changer, enabling swift mobility for critical cases and improving the hospital’s overall efficiency in disease outbreak responses.
ADF has long been at the forefront of major health interventions in Nigeria, from combating malnutrition and polio to supporting disease control during pandemics. This gesture to Mainland Hospital is one of many strategic moves reflecting its broader mission to strengthen Nigeria’s healthcare infrastructure.
-
Feature/OPED5 years ago
Davos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz2 years ago
Estranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years ago
Sort Codes of GTBank Branches in Nigeria
-
Economy2 years ago
Subsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking2 years ago
First Bank Announces Planned Downtime
-
Sports2 years ago
Highest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn
-
Technology4 years ago
How To Link Your MTN, Airtel, Glo, 9mobile Lines to NIN